Holding(s) in Company
22 December 2004 - 10:04PM
UK Regulatory
RNS Number:7260G
Cambridge Antibody Tech Group PLC
22 December 2004
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1) Name of company
Cambridge Antibody Technology Group plc
2) Name of shareholder having a major interest
OrbiMed Advisors LLC
3) Please state whether notification indicates that it is in respect of
holding of the shareholder named in 2 above or in respect of a
non-beneficial interest or in the case of an individual holder if it is a
holding of that person's spouse or children under the age of 18
As in 2 above
4) Name of the registered holder(s) and, if more than one holder, the
number of shares held by each of them
OrbiMed Advisors LLC
5) Number of shares/amount of stock acquired
Nil
6) Percentage of issued class
Nil
7) Number of shares/amount of stock disposed
537,000 Ordinary Shares and
113,000 American Depositary Receipts
8) Percentage of issued class
1.263%
9) Class of security
Ordinary 10 pence shares
10) Date of transaction
20 December 2004
11) Date company informed
21 December 2004
12) Total holding following this notification
2,768,000 of which
2,417,000 are held in the form of ordinary 10 pence shares and
351,000 are held in the form of American Depositary Receipts
13) Total percentage holding of issued class following this notification
5.38%
14) Any additional information
OrbiMed Advisors LLC has investment management discretion over the following
securities:
Caduceus Capital Master Fund Limited
Caduceus Capital II L.P.
UBS Eucalyptus Fund L.L.C.
UBS Eucalyptus Fund Ltd
HFR SHC Aggressive Master Trust
Knightsbridge Post Venture IV L.P.
Knightsbridge Integrated Holdings, V, L.P.
Knightsbridge Netherlands II L.P.
Knightsbridge Integrated Holdings IV Post Venture LP
Knightsbridge Post Venture III LP
Knightsbridge Netherland I LP
Knightsbridge Netherlands III LP
Knightsbridge Integrated Holdings II Limited
Knightsbridge Venture Capital VI LP
Knightsbridge Venture Capital IV L.P.
Knightsbridge Venture Capital III LP
Topanga XIII Inc.
Caduceus Capital III, L.P.
15) Name of contact and telephone number for queries
Justin Hoskins 01223 898589
16) Name and signature of authorised company official responsible for
making this notification
Diane Mellett, Company Secretary
Date of notification: 22 December 2004
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAFAAAEALFFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024